Reumastop

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Reumastop

Quick Facts

Property Description
Active ingredient Indometacin (Indomethacin)
Form Capsule, Suppository, Suspension, Injection
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
General purpose Relief from severe pain, inflammation, and fever
Origin Synthetic indole-acetic acid derivative

Classification and Core Identity: What Type of Medicine is Reumastop?

Reumastop is a trade name whose active compound is the potent generic drug Indometacin (or Indomethacin), a substance classified as a Nonsteroidal Anti-inflammatory Drug (NSAID), belonging to the indole-acetic acid derivative group. It is a synthetic compound known for its strong analgesic, antipyretic, and anti-inflammatory properties, making it clinically recognized for its use in conditions requiring profound anti-inflammatory action.

Indometacin is notably distinguished from many other NSAIDs by its higher therapeutic potency. It is generally reserved for more intense inflammatory states, such as managing the pain associated with gout flares. Being strictly a prescription-only medicine (Rx), Reumastop is not intended for minor, self-managed discomfort, reflecting its significant therapeutic profile and status.


Composition and Structure: Is Indometacin Synthetic or Natural?

The medicine’s function is driven entirely by its single active component, Indometacin, which is a wholly synthetic chemical compound. This compound is formulated into diverse dosage forms, a key feature that includes standard oral capsules, extended-release capsules, suppositories for rectal use, and specialized intravenous injections.

This formulatory flexibility allows for different routes of administration, accommodating various patient needs for systemic delivery when oral intake is contraindicated or rapid action is required. The excipients—or vehicle—vary widely depending on the form, ranging from dry components for capsules to fatty bases for suppositories.


General Purpose: What is the Main Benefit of Taking an Indometacin-Based Drug?

The general purpose of an Indometacin-based drug is to provide effective anti-inflammatory and analgesic relief by tackling the underlying biological causes of discomfort. It works by interfering with the body’s synthesis of chemical messengers—the prostaglandins—which are directly responsible for triggering the sensation of pain, fever, and the process of swelling. This focused action provides a broad-spectrum reduction in the physical manifestations of inflammation, benefiting patients by restoring comfort and mobility.

What side effects are possible with Reumastop?

Possible side effects and safety information

As an indole-acetic acid Nonsteroidal Anti-inflammatory Drug (NSAID), Indometacin (Reumastop) has documented systemic safety characteristics, which are strictly defined in government regulatory sources such as FDA and EMA prescribing labels.


Serious Systemic Risk Warnings

Official labeling documents a risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which may be fatal. This risk may occur early in treatment and increase with duration of use. The medication is contraindicated for treating pain following coronary artery bypass graft (CABG) surgery. Furthermore, there is a risk of serious gastrointestinal (GI) adverse events, including bleeding, ulceration, and perforation of the stomach or intestines, which can occur at any time during use and may be fatal.


Common Adverse Reactions and Organ Systems

The most frequently listed adverse reactions reported across all systems is headache, which is often classified as very common, alongside other Central Nervous System (CNS) effects like dizziness. Common Gastrointestinal reactions include dyspepsia, nausea, and abdominal pain. Other systemic effects documented in official sources include renal toxicity and, rarely, severe hepatotoxicity, such as fulminant hepatitis.


Population-Specific Safety Notes

Older adults are recognized in regulatory documents as being at greater risk for serious GI events and increased frequency of adverse reactions. The medicine is avoided or contraindicated during the later stages of pregnancy due to specific risks of fetal renal dysfunction and premature closure of the fetal ductus arteriosus. Use is also contraindicated in individuals with a history of asthma or allergic-type reactions to aspirin or other NSAIDs.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Indometacin overdose focuses on two primary areas of manifestation: the gastrointestinal system and the central nervous system. Documented signs and symptoms in overdose cases include nausea, vomiting, abdominal pain, headache, dizziness, confusion, drowsiness, and ringing in the ears (tinnitus).

Severe Outcomes and Monitoring

Significant exposure carries the risk of severe, life-threatening outcomes. These potential complications involve serious effects such as seizures, coma, acute renal failure, severe gastrointestinal bleeding, and dangerously low blood pressure (hypotension). Due to this potential for escalation, close clinical monitoring of vital signs and renal function is required in the emergency setting.

Required Emergency Action and Treatment

It is explicitly mandated that individuals seek immediate medical attention right away if an overdose is suspected or has occurred. This action is necessary because there is no specific antidote known for Indometacin poisoning. Management is entirely symptomatic and supportive. For cases of recent and potentially life-threatening ingestion, measures such as gastric lavage and the administration of activated charcoal may be considered as procedural steps.

The regulatory documents emphasize the need for urgent medical care given the drug’s potential for severe systemic toxicity, particularly the heightened risk of acute renal failure in patients with pre-existing renal impairment.

Therapeutic Uses of Reumastop

What Reumastop Treats: Main Uses and Benefits

The primary therapeutic role of Reumastop (Indometacin) is commonly used for managing conditions marked by intense inflammation and pain. The medication is considered relevant across domains where additional symptomatic support is needed, offering supportive relief when symptoms become more noticeable.

It is commonly used for managing conditions characterized by periods of heightened symptoms and severe inflammatory manifestations, including rheumatoid arthritis, ankylosing spondylitis, specific forms of osteoarthritis, acute gouty arthritis, and inflammatory conditions like acute bursitis or tendinitis. The goal of its use is to assist with maintaining functional stability by managing the rapid onset of symptoms that create noticeable physiological strain.


Quick Fact: Symptomatic Support for Inflammation and Stiffness

Domain Conditions Addressed Primary Benefit
Inflammation Severe joint swelling, tenderness, and fever May help ease the overall symptom load
Pain/Function Moderate to severe joint discomfort and stiffness May contribute to improved day-to-day comfort

Eligibility and Restrictions for Use

The eligibility for Reumastop is defined by official regulatory documentation, establishing groups who are strictly prohibited from use and those who require conditional use.

Eligibility Status

Status Population/Condition Regulatory Classification
Contraindicated Pregnancy (for non-neoplastic use) Absolute Exclusion
Contraindicated Severe hypersensitivity to Reumastop Absolute Exclusion
Contraindicated Severe hepatic or advanced renal disease Absolute Exclusion
Not Recommended Lactation (Breastfeeding mothers) Prohibited Use
Restricted Use Older adults (Age ge 65) Conditional Caution
Not Established Most pediatric populations Insufficient Data

Official Eligibility Constraints

Use of Reumastop is prohibited for any patient with a documented history of severe hypersensitivity reactions to the drug or any component. It is also contraindicated in patients with severe pre-existing conditions such as chronic liver disease, alcoholism, preexisting blood dyscrasias, or active, serious infections. Females of reproductive potential must use effective contraception during and for a specified time after treatment, as the drug is strictly contraindicated during pregnancy due to embryo-fetal toxicity. Patients with mild-to-moderate renal or hepatic impairment may be eligible but require close monitoring.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The formulation marketed as Reumastop often contains a combination of ingredients, such as glucosamine, chondroitin, MSM, and various herbal extracts (e.g., Devil's Claw, Ginger, Turmeric). Since this composition is typically classified as a food supplement, it may lack the formal, centralized regulatory interaction labeling found in prescription pharmaceutical documents.

However, the individual components carry known interaction profiles based on established scientific literature:

Product Class/Ingredient Potential Interaction Mechanism
Anticoagulant Medicines (e.g., Warfarin) Glucosamine and certain herbal extracts (e.g., Devil's Claw, Turmeric) may theoretically potentiate the effects of blood thinners, increasing the risk of bruising or bleeding.
Chemotherapy Drugs (e.g., Methotrexate) The combination with certain anti-inflammatory herbs could affect drug metabolism or efficacy, necessitating monitoring.
Antidiabetic Medicines Glucosamine is a type of amino sugar that may affect glucose metabolism. Caution and increased blood glucose monitoring are advised for individuals taking insulin or oral antidiabetic agents.
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Combining this product with prescription or over-the-counter NSAIDs may compound the risk of gastrointestinal side effects.

Individuals using any long-term prescription medication, particularly those for managing diabetes or affecting blood clotting, should consult a healthcare professional before starting or stopping this product. This ensures appropriate monitoring for altered drug effects or potential adverse reactions.

Mechanism of Action

The active compound in Reumastop, Indometacin, exerts its effect through a rapid, multi-domain mechanism centered on modulating nociceptive and inflammatory pathways at both peripheral and central sites.


Core Mechanism: Enzyme Inhibition of Prostaglandin Synthesis

The drug primarily works by non-selective inhibition of the Cyclooxygenase ( COX) enzymes ( COX-1 and COX-2). By blocking these enzymes, Indometacin interrupts the Arachidonic Acid Cascade , thereby suppressing the synthesis of prostaglandins—the key lipid mediators responsible for sensitizing nerves, increasing vascular permeability, and elevating the body's temperature set-point. This initial molecular action modifies early signaling steps that shape systemic physiological outcomes, leading directly to the reduction of excessive physiological responses such as the elevation of the thermoregulatory set-point.


Secondary Mechanism: Cellular and Central Pathway Modulation

In addition to its class effect, Indometacin engages unique mechanisms that influence cellular integrity and central nervous system (CNS) pathways. It contributes to reducing cellular destructive processes by stabilizing lysosomal membranes and reducing the migration of white blood cells at sites of mediator release. Furthermore, its high lipid solubility enables CNS penetration, where it modulates pathways like Nitric Oxide ( NO) signaling. This modulation influences systems exhibiting dysregulated signaling for specific central nociceptive responses, resulting in an altered physiological state within targeted cranial pathways.

Dosage and Administration Information

Official Administration Guidelines

Reumastop (Mycophenolate Mofetil) is administered twice daily (BID) via the oral or intravenous (IV) route, typically initiated immediately following organ transplantation. Official dosing is highly specific to the transplanted organ and patient age.

Administration Details

Transplant Type Adult Dose (BID) Pediatric Dose (BID)
Kidney 1 g 600 mg/m^2 (Max 2 g daily)
Heart/Liver 1.5 g (Oral) / 1 g (IV) 600 mg/m^2 (Max 900 mg/m^2 BID)
  • Oral Administration: It is generally recommended to take Reumastop on an empty stomach (one hour before or two hours after a meal). However, in stable transplant patients, it may be taken with food if necessary. Capsules and tablets must be swallowed whole and should not be crushed or opened to avoid exposure to the powder.

  • Intravenous (IV) Use: The IV solution is a temporary alternative for patients unable to tolerate oral medication and is limited to 14 days of use. IV infusion must be administered slowly over a period of no less than two hours to minimize local adverse reactions. The IV solution should not be mixed with other IV drugs or solutions.

Procedural and Dosing Rules

  1. Preparation: The oral suspension must be reconstituted but must not be mixed with other liquids before administration. The IV form also requires reconstitution.
  2. Missed Dose: If a dose is missed, take the regular amount as soon as remembered, unless it is closer than two hours to the next scheduled dose; in that case, skip the missed dose and resume the normal schedule. Do not take a double dose.
  3. Dose Adjustment: The dose must be reduced or interrupted if the patient develops neutropenia (low white blood cell count), based on the physician's evaluation of the specific clinical factors.

Recent Clinical Evidence

Reumastop: Recent Clinical Evidence

Phase 3 Trial Summary: Clinical Outcomes

Studies have explored a potential mechanism, with investigators exploring the hypothesis related to pain and swelling. Research has examined whether long-term joint function is affected and whether changes in stiffness were observed.

Studies have evaluated whether mobility is affected and whether a reduction in inflammation was measurable. Research has focused on individuals with mild to moderate osteoarthritis (OA), reporting results in Phase 3 trials.

Clinical Research Focus

Dosage and Administration

Research has examined the combination of the active drug with a low dose of a secondary compound. Some studies have focused on individuals initiating treatment at early stages.

Studies have primarily focused on a specific 10 mg/day regimen. Early-stage trials investigated a dose range from 5 mg to 20 mg.

Comparative Studies and Safety

One study explored this treatment in a broad patient group, and it was studied in comparison with other existing treatments when examining severe pain. Studies note that individuals with pre-existing heart conditions were generally excluded from primary trials or represent a specific area of inquiry.

Researchers noted that the most frequently reported events across all trials included mild gastrointestinal discomfort and headache. Research continues to explore potential outcomes and long-term effects in diverse patient groups.

Frequently Asked Questions (FAQ)

Common questions about Reumastop (FAQ)


Q: Is it okay to drink alcohol in moderation while using Reumastop?

A: Regulatory documents state that consuming alcohol while using this medicine is not routinely advised by regulatory documents due to safety concerns. This is because alcohol use may significantly increase the risk of serious side effects, particularly gastrointestinal bleeding, which is a key safety concern noted in the official warnings for this drug class.


Q: How long does it typically take to see any effect from Reumastop?

A: The medicine is quickly absorbed into the body after an oral dose, with the highest concentration in the bloodstream typically reached in about two hours. Official prescribing information describes the medicine's role as providing relief for symptoms like pain, fever, and inflammation, which is related to this initial rapid absorption.


Q: Is it true that Reumastop can interact with common pain relievers?

A: Yes, official sources warn that combining this medicine with certain common pain relievers can be risky. Specifically, using it with aspirin or other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) like ibuprofen or naproxen is a combination typically avoided or requires strict monitoring. This is because the combination significantly increases the chance of serious gastrointestinal side effects.


Q: What types of food or drinks should be avoided while using Reumastop?

A: Official labeling advises that the medicine can be taken with food if necessary, as this may help reduce the chance of an upset stomach. Regulatory documents do not specifically prohibit or list particular foods or beverages that must be avoided while using this drug.


Q: Is Reumastop often prescribed with another medicine?

A: Official documents note that this drug has a known potential to interact with a wide range of other medicines. Due to these interactions, close monitoring and potential adjustments are typically considered when the medicine is used at the same time as other common prescription drugs.


Q: Is Reumastop safe for people who have a history of stomach ulcers?

A: Official warnings indicate that individuals with a past history of peptic ulcers or gastrointestinal bleeding face a greatly increased risk of bleeding. This is a factor that typically requires a careful risk assessment, and official warnings indicate avoidance is sometimes necessary unless the potential benefits are determined to outweigh the known elevated risks.


Q: Does Reumastop help with pain right away?

A: The medicine is rapidly absorbed, which allows the anti-inflammatory action to begin in the body. While its intended effect is the reduction of symptoms like pain and inflammation, the timing of noticeable relief can vary among patients.


Q: Can Reumastop be used for types of arthritis other than the main described use?

A: Yes, official labeling indicates the medicine is approved for the treatment of several related inflammatory conditions. This includes specific types of arthritis, such as rheumatoid arthritis, osteoarthritis, and acute gouty arthritis, as well as conditions like acute painful shoulder.


Q: Do you have to take Reumastop every day?

A: Official proper use information indicates that for the management of chronic conditions, consistent use as directed in the prescribed regimen is typically important to maintain therapeutic effects. The exact regimen and frequency are determined by the prescriber.


Q: Can Reumastop cause changes in mood or anxiety?

A: Official reports of adverse reactions include some effects on the central nervous system. Specifically, regulatory documents list depression as a possible adverse reaction, along with other effects like dizziness.


Q: What happens if Reumastop is taken for a very long time?

A: Official warnings note that the risks of serious side effects, particularly cardiovascular events and gastrointestinal bleeding or ulceration, may increase over time with the duration of use. When used long-term, close monitoring of organ function, such as the kidneys, and blood pressure is typically advised.


Q: Can Reumastop be used by people who have diabetes?

A: While having diabetes is not an absolute prohibition for use, regulatory warnings indicate potential for drug interactions that could affect blood glucose levels. If the medicine is used by someone with diabetes, the regulatory labeling suggests that close monitoring of blood sugar may be necessary.


Q: Are there any known interactions between Reumastop and herbal supplements?

A: General guidance in official sources suggests communicating all products, including herbal supplements and other non-prescription items, to the prescriber. This practice allows for proper assessment of potential interactions before starting the medicine.


Q: Does Reumastop affect the immune system?

A: Official documents describe the medicine's potential to cause anaphylactic reactions (severe allergic responses). The drug is also contraindicated in patients with aspirin-sensitive asthma, which relates to specific immune-mediated or allergic pathways.


Q: Are generic versions of Reumastop available?

A: Yes. The active ingredient in Reumastop, Indometacin, is a widely used compound. Generic versions of this compound have been approved by the FDA for use in certain formulations.


Q: Can Reumastop make a pre-existing condition, like high blood pressure, worse?

A: Yes, official warnings advise that this medicine can make some pre-existing conditions worse. For example, it may impair the effectiveness of blood pressure medications, and official sources indicate that close blood pressure monitoring is typically considered necessary while using the drug.


Q: Why do some people report feeling fatigued when they start Reumastop?

A: Official adverse reaction data collected during clinical trials lists fatigue (which includes malaise and listlessness) as a possible central nervous system side effect. It was reported in a smaller percentage of patients treated with the medicine.


Q: Does Reumastop need a special prescription?

A: Official labeling designates this medicine as 'Rx Only', meaning it is a prescription drug that can only be dispensed by a pharmacist with a valid prescription. It is not classified as a controlled substance that requires highly restricted handling.


Q: Are there different strengths or formulations of Reumastop?

A: Yes, the medicine is available in various forms, including different dosage strengths and types. These forms typically include oral capsules in multiple strengths, extended-release capsules, and specialized suppositories.


Q: What is the process for discontinuing Reumastop?

A: Discontinuation is a treatment adjustment that is typically necessary when specific serious findings are observed. For example, regulatory documents state that discontinuation is warranted if abnormal liver function tests persist or worsen, or if clinical signs of severe liver disease develop.


Q: Can Reumastop interact with flu shots or other common vaccines?

A: Some studies have examined the concurrent use of NSAIDs like this medicine around the time of vaccination. These studies suggest a potential for a decreased immune response to some vaccines if the medicine is taken at the same time.


Q: How does the official literature describe the long-term effectiveness of Reumastop?

A: Official labeling describes the medicine as an effective anti-inflammatory agent. It is considered appropriate for long-term use in managing the symptoms of chronic conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis.


Q: Is it normal to feel a bit nauseous after starting Reumastop?

A: Nausea is listed in the official documents as one of the most commonly reported adverse reactions. It is a frequent side effect experienced by a documented percentage of patients treated with the medicine.


Q: What is the main reason a person might need to stop using Reumastop?

A: Regulatory warnings indicate that the medicine is typically discontinued when severe adverse events occur. These serious events include signs of major cardiovascular issues like heart attack or stroke, severe gastrointestinal bleeding, or significant liver disease (hepatotoxicity).

How should Reumastop be stored and disposed of?

How to Store and Dispose of Reumastop (Indometacin)

Official regulatory labeling dictates strict conditions to maintain the stability and safety of Indometacin-based medicines.

Required Storage and Handling

Reumastop must be stored at controlled room temperature, typically between 20 C and 25 C, and kept away from excess heat and moisture. The medicine must remain in its tightly closed, original container to protect it from environmental degradation. It is a mandatory requirement to store the medication out of the sight and reach of children and to lock safety caps securely. For the injection form, any unused solution must be discarded immediately after preparation, as it is unstable.

Official Disposal Rules

Do not keep outdated or unused medicine. The preferred method for disposal is through an official drug take-back program. If a program is unavailable, the medicine should be mixed with an undesirable substance (like coffee grounds or cat litter) in a sealed bag and thrown in the trash. Do not flush Indometacin down the toilet or pour it down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Reumastop found in:

A-Z Index: